First Post

My first post here I believe. I tend to not like influencing what others buy, but...the site needs a revival. I recently got back into the stock game after a short break, and screened all of the publicly traded biotechs. Of them all I have narrowed it down to two that I believe may yield a nice quick profit and/or decent gains.

Aeterna, Inc. AEZS - http://www.aezsinc.com/
A biotech specializing in oncology and endocrine therapy. They have several products in their pipeline and enough cash to push the main ones forward (something like $40 million). One of their drugs, Perifosine, has been granted orphan-drug and fast track designation by the FDA, and is in phase II for indications aside from its primary. Price at recommendation: $2.01 AH

Neuralstem (CUR) - A biotech using stem cell technology to treat ailments of the CNS. I am still a bit mixed on this one, but I do believe that it holds potential and will likely buy in at some point. Price at recommendation: $1.85 AH

In addition, for long-term hold investments I have been recommending: JNJ, PEP, INTC, COP, ATVI, BMY, and V. Six of the seven pay dividends quarterly, ATVI being the exception, and all are pretty solid companies in terms of ethics and cash. JNJ> recently added Crucell to its inventory, INTC is a leader in the semi-conductor field, BMY just got approval for its melanoma drug, and ATVI is overflowing with cash and still profitting from World of WarCraft, Call of Duty, and looks to have a good year if Star Craft II expansion I and >Diablo three are released this year. Buy them up, enroll in a "DRIP", and perhaps you can someday live off of dividends or at least have a child/grandchild that can. Invest wisely, take responsibility for your decisions, and good luck! TTM


"EDIT: During my second post I found out how to edit this former wall of text; it should be more reader friendly now. No content has changed." -TTM